
AdvaMed® Post COVID-19 Policy Document
This document identifies new laws and policies that should remain in place at the conclusion of the PHE.

This document identifies new laws and policies that should remain in place at the conclusion of the PHE.

Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.

The Chinese government announced a process to export particular devices without NMPA approval.

View a flow chart of the evaluation process.

This guidance helps member companies support decision-making and mitigate compliance risks.